Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflammation in pleural effusions

Annals of Clinical and Laboratory Science

Volumn 40, Issue 4, 2010, Pages 342-347

  Lee, Moon Hee ^a   Nahm, Chung Hyun ^a   Choi, Jong Weon ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

Plasminogen activator inhibitor type I; Pleural effusions; Thrombin antithrombin III complex; Tuberculosis; Tumor necrosis factor

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; FIBRINOLYSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANTITHROMBIN III; CYTOKINES; FEMALE; FIBRINOLYSIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLEURAL EFFUSION; SEVERITY OF ILLNESS INDEX;

EID: 77958031488     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mutsaers SE, Prele CM, Brody AR, Idell S. Pathogenesis of pleural fibrosis. Respirology 2004;9:428-440.
2. Hua CC, Chang LC, Chen YC, Chang SC. Proinflam-matory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 1999;116:1292-1296.
3. Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest 2005;128:690-697.
4. Philip-Joët F, Alessi MC, Philip-Joët C, Aillaud M, Barriere JR, Arnaud A, Juhan-Vague I. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 1995;8:1352-1356.
5. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77:507-513.
6. Lin FC, Chen YC, Chen FJ, Chang SC. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions. Clin Immunol 2005;116:166-173.
7. Schrecengost JE, LeGallo RD, Boyd JC, Moons KG, Gonias SL, Rose CE Jr, Bruns DE. Comparison of diagnostic accuracies in outpatients and hospitalized patients of D-dimers testing for the evaluation of suspected pulmonary embolism. Clin Chem 2003;49: 1483-1490.
8. Ohlmann P, Faure A, Morel O, Kindo M, Jesel L, Radulescu B, Billaud P, Meyer N, Petit H, Trinh A, Epailly E, Roul G, Chauvin M, Mazzucotelli JP, Eisenmann B, Bareiss P. Lower circulating Sta-Liatest D-Di levels in patients with aortic intramural hematoma compared with classical aortic dissection. Crit Care Med 2009;37:899-901.
9. Vaz MA, Vargas FS, Marinho FC, D'Amico EA, Rocha TR, Teixeira LR. Does the evaluation of coagulation factors contribute to etiological diagnosis of pleural effusions? Clinics 2009;64:891-895.
10. Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991;144:187-194.
11. Mutsaers SE, Wilkosz S. Structure and function of mesothelial cells. Cancer Treat Res 2007;134:1-19.
12. Whawell SA, Thompson JN. Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur J Surg 1995;161:315-318.
13. Gursel G, Gokcora N, Elbeg S, Samurkasoglu B, Ekim N. Tumor necrosis factor-alpha (TNF-alpha) in pleural fluids. Tuber Lung Dis 1995;76:370-371.
14. Soderblom T, Nyberg P, Teppo AM, Klockars M, Riska H, Pettersson T. Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy. Eur Respir J 1996;9:1652-1655.
15. Chen SC, Chen W, Hsu WH, Yu YH, Shih CM. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema. Lung 2006;184: 141-145.
16. Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, Sahn S, Weinstein RA, Yusen RD. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;118:1158-1171.
17. Daniil ZD, Zintzaras E, Kiropoulos T, Papaioannou AI, Koutsokera A, Kastanis A, Gourgoulianis KI. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J 2007;30:957-964.
18. Castano Vidriales JL, Amores Antequera C. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions. Eur J Med 1992;1:201-207.
19. de Pablo A, Villena V, Echave-Sustaeta J, Encuentra AL. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 1997;112:1293-1297.